SCHEMBL712239

SCHEMBL712239

CC(=CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)CC=C(C)C(=O)O)C(=O)O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CD81 P60033 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12987146 1.00 CD81 (0.30) CD81
SCHEMBL17784178 0.98
SCHEMBL1004867 0.94 THRB (0.34)
SCHEMBL4272193 0.92 THRB (0.38)
SCHEMBL532522 0.92 THRB (0.38)
SCHEMBL1004243 0.92 THRB (0.38)
SCHEMBL4277057 0.92 THRB (0.38)
SCHEMBL532520 0.92 THRB (0.38)
SCHEMBL532859 0.92 THRB (0.31)
SCHEMBL532861 0.92 THRB (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240142377-A1 DYES UNDERGOING CHANGES IN COLOR AND FLUORESCENCE UPON BINDING OF ORGANIC OXO COMPOUNDS BUNDESREPUBLIK DEUTSCHLAND, VERTRETEN DURCH DEN BUNDESMINISTER FÜR WIRTSCHAFT UND ENERGIE, DIESER VE (DE) 2024-05-02 US disclosed
EP-4255897-A1 DYES UNDERGOING CHANGES IN COLOR AND FLUORESCENCE UPON BINDING OF ORGANIC OXO COMPOUNDS Bundesrepublik Deutschland, vertreten durch den Bundesminister für Wirtschaft und Energie, dieser vertreten durch den Präsidenten der (DE) 2023-10-11 EP disclosed
WO-2022122402-A1 DYES UNDERGOING CHANGES IN COLOR AND FLUORESCENCE UPON BINDING OF ORGANIC OXO COMPOUNDS BUNDESREPUBLIK DEUTSCHLAND, VERTRETEN DURCH DEN BUNDESMINISTER FÜR WIRTSCHAFT UND ENERGIE, DIESER VERTRETEN DURCH DEN PRÄSIDENTEN DER BUNDESANSTALT FÜR MATERIALFORSCHUNG UND -PRÜFUNG, (BAM) (DE) 2022-06-16 WO disclosed
US-11156750-B2 Laminated diffractive optical element and method for manufacturing laminated diffractive optical element CANON KABUSHIKI KAISHA (JP) 2021-10-26 US disclosed
US-20210223437-A1 OPTICAL ELEMENT AND METHOD FOR MANUFACTURING THE SAME CANON KK (JP) 2021-07-22 US disclosed
US-10996375-B2 Optical element and method for manufacturing the same CANON KABUSHIKI KAISHA (JP) 2021-05-04 US disclosed
EP-3385760-B1 OPTICAL ELEMENT AND METHOD FOR MANUFACTURING THE SAME CANON KK (JP) 2020-11-11 EP disclosed
EP-3385760-A1 OPTICAL ELEMENT AND METHOD FOR MANUFACTURING THE SAME CANON KABUSHIKI KAISHA (JP) 2018-10-10 EP disclosed
US-20180143350-A1 OPTICAL ELEMENT AND METHOD FOR MANUFACTURING THE SAME CANON KK (JP) 2018-05-24 US disclosed
EP-3032295-B1 METHOD FOR MAKING AN OPTICAL ELEMENT CANON KK (JP) 2018-05-02 EP disclosed
EP-2574966-B1 Optical element and method for manufacturing the same CANON KK (JP) 2016-02-10 EP disclosed
EP-2574966-A2 Optical element and method for manufacturing the same Canon Kabushiki Kaisha (JP) 2013-04-03 EP disclosed
US-20130077170-A1 OPTICAL ELEMENT AND METHOD FOR MANUFACTURING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-03-28 US disclosed
WO-2012137452-A1 OPTICAL ELEMENT AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT CANON KABUSHIKI KAISHA (JP) 2012-10-11 WO disclosed
US-8217081-B2 Polymerizable biomedical composition The United States of America as represented by the Secretary of Commerce, the National Institute of Standards and Technology (US) 2012-07-10 US disclosed
US-8124324-B2 Laminated diffractive optical element and resin composition therefor CANON KABUSHIKI KAISHA (JP) 2012-02-28 US disclosed
EP-2081056-B1 Laminated diffractive optical element and resin composition therefor CANON KK (JP) 2011-01-05 EP disclosed
US-20100256242-A1 POLYMERIZABLE BIOMEDICAL COMPOSITION GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF COMMERCE, THE NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY 2010-10-07 US disclosed
US-20090190224-A1 LAMINATED DIFFRACTIVE OPTICAL ELEMENT AND RESIN COMPOSITION THEREFOR CANON KABUSHIKI KAISHA (JP) 2009-07-30 US disclosed
EP-2081056-A2 Laminated diffractive optical element and resin composition therefor Canon Kabushiki Kaisha (JP) 2009-07-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256242-A1 POLYMERIZABLE BIOMEDICAL COMPOSITION PUF60, ARGLU1, ASS1 CD81 1320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.